TDACW
Translational Development Acquisition Corp.
NASDAQ · Financial Services · Financial - Conglomerates · US
$1.15
−3.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.46x
- PEG TTM
- —
- Price / book
- 0.13x
- Price / sales
- —
- Price / cash flow
- -23.36x
Enterprise value
- Enterprise value
- $20.9M
- EV / sales
- —
- EV / EBITDA
- -15.82x
- EV / EBIT
- -15.82x
- Market cap
- $19.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026